BioSpace News Archive

Biotech Bay

Adamas Announces Pricing of Public Offering of Common Stock

The offering is expected to close on January 26, 2018, subject to customary closing conditions.

January 24, 2018
·
3 min read
Business

Sanofi: Availability of the Pre-quarterly Results Communication - Jan. 24, 2018

Each quarter, Sanofi prepares this document to assist in the financial modeling of the Group’s quarterly results.

January 24, 2018
·
3 min read
Drug Development

MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis

FDA grants Fast Track designation to margetuximab for treatment of metastatic breast cancer.

January 24, 2018
·
5 min read
Drug Development

Abstract Outlining Pre-Hospital Stroke Study With Diffusion Pharmaceuticals’ TSC To Be Presented at the International Stroke Conference

The abstract introduces the design and rationale for the planned Phase 2 PHAST-TSC study.

January 24, 2018
·
6 min read
Policy

FDA Has Approved Faron’s Traumakine IND

The FDA has already proposed that Faron can proceed directly to BLA pending positive results from the two on-going Phase III trials

January 24, 2018
·
3 min read
Business

pSivida Corp. Announces Second Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information

Management will host a conference call to review the results at 4:30 p.m. ET on the same day.

January 24, 2018
·
2 min read
Bio NC

First Patient Enrolled in Tryton Post Approval Study

Tryton today announced that the first patient has been enrolled in the post approval study to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.

January 24, 2018
·
2 min read
Pharm Country

Stemline Therapeutics Prices $51.8M Public Offering of Common Stock

The offering is expected to close on January 26, 2018, subject to customary closing conditions.

January 24, 2018
·
4 min read
Policy

FDA Grants Approval to Shire for Technology Transfer of CINRYZE Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site

Shire will begin commercial manufacturing of Cinryze drug product in Vienna in the first quarter of 2018.

January 24, 2018
·
9 min read
Poietis Announces the First Commercial Launch of a Tissue Model Manufactured by Bioprinting

Poietis, a leading company in 4D bioprinting solutions, today announces the commercial launch of Poieskin, its first bioprinted skin model.

January 24, 2018
·
2 min read